Who is the Prostate Cancer iPRS™ test for?

This test is intended for individuals assigned male at birth who:

• Are 30–75 years old, (ages <40 and >70 receive a remaining lifetime risk score only),
• Do not have a personal history of prostate cancer, and
• Do not carry a known pathogenic variant in a prostate cancer–associated gene.

It is designed for the large majority of individuals whose prostate cancer risk cannot be explained by a single high-impact hereditary gene mutation.